NZ318501A
(en)
*
|
1995-09-21 |
1999-06-29 |
Pharma Pass Llc |
Novel composition containing an acid-labile omeprazole and process for its preparation
|
US6699885B2
(en)
*
|
1996-01-04 |
2004-03-02 |
The Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and methods of using same
|
US5840737A
(en)
|
1996-01-04 |
1998-11-24 |
The Curators Of The University Of Missouri |
Omeprazole solution and method for using same
|
US6645988B2
(en)
*
|
1996-01-04 |
2003-11-11 |
Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and method of using same
|
US6489346B1
(en)
*
|
1996-01-04 |
2002-12-03 |
The Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and method of using same
|
SE9602442D0
(sv)
*
|
1996-06-20 |
1996-06-20 |
Astra Ab |
Administration of pharmaceuticals
|
SE9700885D0
(sv)
*
|
1997-03-12 |
1997-03-12 |
Astra Ab |
New pharmaceutical formulation
|
US6197331B1
(en)
|
1997-07-24 |
2001-03-06 |
Perio Products Ltd. |
Pharmaceutical oral patch for controlled release of pharmaceutical agents in the oral cavity
|
PT1003554E
(pt)
*
|
1997-07-25 |
2005-03-31 |
Altana Pharma Ag |
Inibidor da bomba de protoes em combinacao terapeutica com substancias antibacterianas
|
DE19732903A1
(de)
|
1997-07-30 |
1999-02-04 |
Falk Pharma Gmbh |
Pellet-Formulierung zur Behandlung des Intestinaltraktes
|
ES2137862B1
(es)
*
|
1997-07-31 |
2000-09-16 |
Intexim S A |
Preparacion farmaceutica oral que comprende un compuesto de actividad antiulcerosa y procedimiento para su obtencion.
|
AU740757B2
(en)
*
|
1997-10-09 |
2001-11-15 |
Perio Products Ltd. |
Delayed total release gastrointestinal drug delivery system
|
SE9704870D0
(sv)
*
|
1997-12-22 |
1997-12-22 |
Astra Ab |
New pharmaceutical formulation I
|
SE9704869D0
(sv)
*
|
1997-12-22 |
1997-12-22 |
Astra Ab |
New pharmaceutical formulaton II
|
KR100572090B1
(ko)
*
|
1998-02-24 |
2006-04-17 |
액티브 바이오틱스 인코포레이티드 |
상승작용이 있는 항균제 조성물, 그것을 함유하는 의약 및 소화기질환 치료제, 그들의 제조 방법, 및 그에 관련된 제제
|
EP1069911A1
(de)
*
|
1998-04-06 |
2001-01-24 |
Dalhousie University |
Neuartige nitroreduktase und ihre therapeutische verwendung
|
DE19820801A1
(de)
*
|
1998-05-09 |
1999-11-25 |
Gruenenthal Gmbh |
Orale Arzneiformen mit reproduzierbarer Wirkstofffreisetzung von Gatifloxacin oder pharmazeutisch verwendbaren Salzen oder Hydraten
|
US7122207B2
(en)
*
|
1998-05-22 |
2006-10-17 |
Bristol-Myers Squibb Company |
High drug load acid labile pharmaceutical composition
|
WO2000009092A1
(en)
|
1998-08-12 |
2000-02-24 |
Byk Gulden Lomberg Chemische Fabrik Gmbh |
Oral administration form for pyridin-2-ylmethylsulfinyl-1h-benzimidazoles
|
US6531152B1
(en)
|
1998-09-30 |
2003-03-11 |
Dexcel Pharma Technologies Ltd. |
Immediate release gastrointestinal drug delivery system
|
DE19850445A1
(de)
*
|
1998-11-02 |
2000-05-04 |
Falk Pharma Gmbh |
Arzneimittel zur topischen Behandlung entzündlicher Darmerkrankungen
|
IL142629A0
(en)
*
|
1998-11-18 |
2002-03-10 |
Astra Ab |
Improved chemical process and pharmaceutical formulation
|
US6632451B2
(en)
|
1999-06-04 |
2003-10-14 |
Dexcel Pharma Technologies Ltd. |
Delayed total release two pulse gastrointestinal drug delivery system
|
ES2168043B1
(es)
*
|
1999-09-13 |
2003-04-01 |
Esteve Labor Dr |
Forma farmaceutica solida oral de liberacion modificada que contiene un compuesto de bencimidazol labil en medio acido.
|
RU2230556C2
(ru)
|
1999-10-29 |
2004-06-20 |
Эро-Селтик, С.А. |
Препаративные формы гидрокодона с контролируемым высвобождением
|
US10179130B2
(en)
|
1999-10-29 |
2019-01-15 |
Purdue Pharma L.P. |
Controlled release hydrocodone formulations
|
US6544555B2
(en)
|
2000-02-24 |
2003-04-08 |
Advancis Pharmaceutical Corp. |
Antibiotic product, use and formulation thereof
|
DE10030318C1
(de)
*
|
2000-06-27 |
2002-02-28 |
Byk Gulden Lomberg Chem Fab |
Arzneimittelverpackung für die Eradikationstherapie
|
AU2001296908A1
(en)
*
|
2000-09-29 |
2002-04-08 |
Geneva Pharmaceuticals, Inc. |
Proton pump inhibitor formulation
|
US20020068078A1
(en)
|
2000-10-13 |
2002-06-06 |
Rudnic Edward M. |
Antifungal product, use and formulation thereof
|
AU2002227383B2
(en)
|
2000-10-30 |
2004-07-08 |
Euro-Celtique S.A. |
Controlled release hydrocodone formulations
|
CA2359812C
(en)
|
2000-11-20 |
2004-02-10 |
The Procter & Gamble Company |
Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
|
JP4241041B2
(ja)
*
|
2000-12-07 |
2009-03-18 |
ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング |
酸分解性活性成分を含有するペースト形の医薬品製造物
|
JP2002234842A
(ja)
*
|
2001-02-09 |
2002-08-23 |
Kyowa Yakuhin Kogyo Kk |
内服腸溶性製剤
|
SE0101379D0
(sv)
*
|
2001-04-18 |
2001-04-18 |
Diabact Ab |
Komposition som hämmar utsöndring av magsyra
|
AU4061702A
(en)
*
|
2001-05-15 |
2003-04-03 |
Mcneil-Ppc, Inc. |
Dip coating compositions containing starch or dextrin
|
US20030070584A1
(en)
|
2001-05-15 |
2003-04-17 |
Cynthia Gulian |
Dip coating compositions containing cellulose ethers
|
ATE480226T1
(de)
*
|
2001-06-22 |
2010-09-15 |
Bend Res Inc |
Pharmazeutische zusammensetzung enthaltend schwer lösliche und säureempfindliche arzneistoffe und neutralisierte anionische polymere
|
DE60233874D1
(de)
*
|
2001-06-22 |
2009-11-12 |
Pfizer Prod Inc |
Pharmazeutische zusammensetzungen enthaltend dispersionen aus arzneistoffen und neutralen polymeren
|
US8309118B2
(en)
|
2001-09-28 |
2012-11-13 |
Mcneil-Ppc, Inc. |
Film forming compositions containing sucralose
|
US8101209B2
(en)
|
2001-10-09 |
2012-01-24 |
Flamel Technologies |
Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
|
FR2830447B1
(fr)
*
|
2001-10-09 |
2004-04-16 |
Flamel Tech Sa |
Forme galenique orale microparticulaire pour la liberation retardee et controlee de principes actifs pharmaceutiques
|
JP2005521662A
(ja)
*
|
2002-01-25 |
2005-07-21 |
サンタラス インコーポレイティッド |
プロトンポンプ阻害剤の経粘膜送達
|
DE10211289A1
(de)
|
2002-03-14 |
2003-09-25 |
Basf Ag |
Kombination von Polyvinylacetat von wasserunlöslichen, säureunlöslichen oder alkaliunlöslichen Polymeren zur Hestellung von Filmüberzügen mit sehr kontrollierter Freisetzung und hoher Stabilität
|
US20030175342A1
(en)
*
|
2002-03-14 |
2003-09-18 |
Karl Kolter |
Coated pharmaceutical single-unit delayed-release forms, based on polyvinyl acetate
|
MXPA04009968A
(es)
|
2002-04-09 |
2004-12-13 |
Flamel Tech Sa |
Formulacion farmaceutica oral bajo forma de suspension acuosa de microcapsulas que permiten la liberacion modificada de principio (s) activo (s).
|
KR20050005437A
(ko)
*
|
2002-04-09 |
2005-01-13 |
플라멜 테크놀로지스 |
아목시실린의 변형 방출을 위한 마이크로캡슐 수성 현탁액형태의 경구 제약학적 제제
|
US7125563B2
(en)
|
2002-04-12 |
2006-10-24 |
Dava Pharmaceuticals, Inc. |
Sustained release pharmaceutical preparations and methods for producing the same
|
US20030228363A1
(en)
*
|
2002-06-07 |
2003-12-11 |
Patel Mahendra R. |
Stabilized pharmaceutical compositons containing benzimidazole compounds
|
DK1519717T3
(da)
*
|
2002-07-05 |
2011-01-10 |
Temrel Ltd |
Sammensætning til kontrolleret frisætning
|
US20040013737A1
(en)
*
|
2002-07-19 |
2004-01-22 |
Philippe Becourt |
Taste masked oral composition of telithromycin
|
WO2004009059A1
(en)
*
|
2002-07-19 |
2004-01-29 |
Aventis Pharma S.A. |
Taste masked oral composition of telithromycin
|
BR0312876A
(pt)
*
|
2002-07-25 |
2005-06-28 |
Pharmacia Corp |
Método de preparação de formas de dosagem sólidas revestidas em duas camadas compreendendo um polìmero insolúvel em água e um agente formador de poros solúvel em água
|
US7429619B2
(en)
*
|
2002-08-02 |
2008-09-30 |
Mcneil Consumer Healthcare |
Polyacrylic film forming compositions
|
US20040028737A1
(en)
*
|
2002-08-12 |
2004-02-12 |
Kopran Research Laboratories Limited |
Enteric coated stable oral pharmaceutical composition of acid unstable drug and process for preparing the same
|
US20050191353A1
(en)
*
|
2002-08-16 |
2005-09-01 |
Amit Krishna Antarkar |
Process for manufacture of stable oral multiple unit pharmaceutical composition containing benzimidazoles
|
WO2004016242A2
(en)
*
|
2002-08-16 |
2004-02-26 |
Themis Laboratories Private Limited |
A process for manufacture of stable oral multiple units pharamceutical composition containing benzimidazoles
|
MY148805A
(en)
*
|
2002-10-16 |
2013-05-31 |
Takeda Pharmaceutical |
Controlled release preparation
|
EP2596792A1
(de)
*
|
2002-10-16 |
2013-05-29 |
Takeda Pharmaceutical Company Limited |
Stabile, feste Präparate
|
SE0203065D0
(sv)
*
|
2002-10-16 |
2002-10-16 |
Diabact Ab |
Gastric acid secretion inhibiting composition
|
EP1558211A2
(de)
*
|
2002-10-30 |
2005-08-03 |
Pharmacia Corporation |
Orale tabletten mit verlängerter freisetzung und verfahren für deren herstellung sowie verwendung derselben
|
AU2002361495A1
(en)
*
|
2002-12-24 |
2004-07-22 |
Lupin Limited |
Enteric coated fluoxetine composition
|
US20040146558A1
(en)
*
|
2003-01-28 |
2004-07-29 |
Kyowa Pharmaceutical Co., Ltd. |
Oral enteric-coated preparation
|
JP2006518751A
(ja)
*
|
2003-02-20 |
2006-08-17 |
サンタラス インコーポレイティッド |
胃酸の急速かつ持続的な抑制のための新規製剤、オメプラゾール制酸剤複合体−即時放出物
|
CA2518780C
(en)
*
|
2003-03-12 |
2014-05-13 |
Takeda Pharmaceutical Company Limited |
Drug composition having active ingredient adhered at high concentration to spherical core
|
MXPA05010636A
(es)
*
|
2003-04-04 |
2005-12-12 |
Pharmacia Corp |
Comprimidos de multiparticulas preparados por compresion de liberacion oral prolongada.
|
BR0300882A
(pt)
*
|
2003-04-09 |
2005-05-10 |
Cmax Otimizacao De Resultados |
Composições farmacêuticas, método e uso de formulação para tratamento e prevenção de infecções associadas com helicobacter pylori em mamìferos e no ser humano
|
PE20050150A1
(es)
|
2003-05-08 |
2005-03-22 |
Altana Pharma Ag |
Una forma de dosificacion que contiene (s)-pantoprazol como ingrediente activo
|
CL2004000983A1
(es)
|
2003-05-08 |
2005-03-04 |
Altana Pharma Ag |
Composicion farmaceutica oral en forma de tableta que comprende a pantoprazol magnetico dihidratado, en donde la forma de tableta esta compuesto por un nucleo, una capa intermedia y una capa exterior; y uso de la composicion farmaceutica en ulceras y
|
US8986736B2
(en)
*
|
2003-06-24 |
2015-03-24 |
Baxter International Inc. |
Method for delivering particulate drugs to tissues
|
EP2112920B1
(de)
|
2003-06-26 |
2018-07-25 |
Intellipharmaceutics Corp. |
Protonenpumpeninhibitoren enthaltende kapseln, die verschieden aufgebaute untereinheiten zur verzögerten wirkstofffreisetzung enthalten
|
US20050042277A1
(en)
*
|
2003-07-17 |
2005-02-24 |
Irukulla Srinivas |
Pharmaceutical compositions having a swellable coating
|
US8993599B2
(en)
|
2003-07-18 |
2015-03-31 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
WO2005009364A2
(en)
|
2003-07-21 |
2005-02-03 |
Advancis Pharmaceutical Corporation |
Antibiotic product, use and formulation thereof
|
WO2005009368A2
(en)
|
2003-07-21 |
2005-02-03 |
Advancis Pharmaceutical Corporation |
Antibiotic product, use and formulation thereof
|
WO2005009365A2
(en)
|
2003-07-21 |
2005-02-03 |
Advancis Pharmaceutical Corporation |
Antibiotic product, use and formulation thereof
|
WO2005016311A1
(en)
|
2003-08-11 |
2005-02-24 |
Advancis Pharmaceutical Corporation |
Robust pellet
|
AU2004264356B2
(en)
|
2003-08-12 |
2011-01-27 |
Shionogi, Inc. |
Antibiotic product, use and formulation thereof
|
WO2005023184A2
(en)
*
|
2003-08-29 |
2005-03-17 |
Advancis Pharmaceuticals Corporation |
Antibiotic product, use and formulation thereof
|
WO2005020954A2
(en)
*
|
2003-09-03 |
2005-03-10 |
Agi Therapeutics Limited |
Proton pump inhibitor formulations, and methods of preparing and using such formulations
|
WO2005027877A1
(en)
|
2003-09-15 |
2005-03-31 |
Advancis Pharmaceutical Corporation |
Antibiotic product, use and formulation thereof
|
TWI372066B
(en)
|
2003-10-01 |
2012-09-11 |
Wyeth Corp |
Pantoprazole multiparticulate formulations
|
US8168228B2
(en)
*
|
2003-10-17 |
2012-05-01 |
Sandoz Ag |
Antibiotic clarithromycin micropellet compositions
|
DE10353186A1
(de)
*
|
2003-11-13 |
2005-06-16 |
Röhm GmbH & Co. KG |
Mehrschichtige Arzneiform, enthaltend eine in Bezug auf die Wirkstoffabgabe modulatorisch wirkende Substanz
|
WO2005051362A2
(en)
*
|
2003-11-28 |
2005-06-09 |
Ranbaxy Laboratories Limited |
Oral benzimidazole compositions comprising an active core, an optional separating layer and an enteric coating
|
US20050181052A1
(en)
*
|
2004-02-17 |
2005-08-18 |
Patel Satishkumar A. |
Lansoprazole microtablets
|
ES2376466T3
(es)
|
2004-05-07 |
2012-03-14 |
Nycomed Gmbh |
Forma de dosificación farmacéutica que comprende peletes, as�? como su procedimiento de fabricación.
|
US8815916B2
(en)
|
2004-05-25 |
2014-08-26 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
US8906940B2
(en)
|
2004-05-25 |
2014-12-09 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
EP1768668A2
(de)
|
2004-06-16 |
2007-04-04 |
Tap Pharmaceutical Products, Inc. |
Multi-ppi-dosierform
|
WO2006014427A1
(en)
|
2004-07-02 |
2006-02-09 |
Advancis Pharmaceutical Corporation |
Tablet for pulsed delivery
|
DE102004035936A1
(de)
*
|
2004-07-23 |
2006-03-16 |
Röhm GmbH & Co. KG |
Mehrschichtige Arzneiform
|
US10624858B2
(en)
*
|
2004-08-23 |
2020-04-21 |
Intellipharmaceutics Corp |
Controlled release composition using transition coating, and method of preparing same
|
WO2006026829A1
(en)
*
|
2004-09-09 |
2006-03-16 |
Metelli Pty Ltd |
Stable paste composition of enteric coated acid labile active agent and use thereof
|
AR051654A1
(es)
*
|
2004-11-04 |
2007-01-31 |
Astrazeneca Ab |
Nuevas formulaciones de pellets de liberacion modificada para inhibidores de la bomba de protones
|
AR052225A1
(es)
*
|
2004-11-04 |
2007-03-07 |
Astrazeneca Ab |
Formulaciones de tabletas de liberacion modificada par inhibidores de la bomba de protones
|
US8658216B2
(en)
|
2004-12-23 |
2014-02-25 |
Ranbaxy Laboratories Limited |
Stable oral benzimidazole compositions and process of preparation thereof
|
US20080279951A1
(en)
*
|
2005-02-02 |
2008-11-13 |
Rajesh Gandhi |
Stable Oral Benzimidazole Compositions Prepared by Non-Aqueous Layering Process
|
CN101111230B
(zh)
*
|
2005-03-29 |
2010-05-19 |
赢创罗姆有限责任公司 |
包含对活性成分具有调节释放作用的小丸的多颗粒药用形式
|
KR20070119658A
(ko)
*
|
2005-03-29 |
2007-12-20 |
에보니크 룀 게엠베하 |
활성 성분 방출에 대한 조절 효과를 가지는 물질을포함하는 펠렛을 포함하는 다중 미립자 제약 형태
|
CA2608444A1
(en)
*
|
2005-05-13 |
2007-03-15 |
Combino Pharm, S.L. |
Formulations containing pantoprazole free acid and its salts
|
US20070087056A1
(en)
*
|
2005-08-09 |
2007-04-19 |
Claudia Guthmann |
Pharmaceutical form with sustained pH-independent active ingredient release for active ingredients having strong pH-dependent solubility
|
KR100591142B1
(ko)
*
|
2005-11-04 |
2006-06-20 |
지엘팜텍 주식회사 |
파록세틴을 활성물질로 함유하는 장용성 서방형 정제
|
WO2007063552A1
(en)
*
|
2005-12-02 |
2007-06-07 |
Lupin Limited |
Stable taste masked formulations of cephalosporins
|
US8778924B2
(en)
|
2006-12-04 |
2014-07-15 |
Shionogi Inc. |
Modified release amoxicillin products
|
US8357394B2
(en)
|
2005-12-08 |
2013-01-22 |
Shionogi Inc. |
Compositions and methods for improved efficacy of penicillin-type antibiotics
|
US10064828B1
(en)
|
2005-12-23 |
2018-09-04 |
Intellipharmaceutics Corp. |
Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
|
EP1803450A1
(de)
*
|
2006-01-03 |
2007-07-04 |
Ferrer Internacional, S.A. |
Pharmazeutische Zusammensetzungen zur Eradikation von Helicobacter Pylori
|
EP1973532A1
(de)
*
|
2006-01-16 |
2008-10-01 |
Jubilant Organosys Limited |
Stabile pharmazeutische formulierung einer säurelabilen verbindung und herstellungsverfahren dafür
|
WO2007092717A1
(en)
*
|
2006-02-07 |
2007-08-16 |
Fmc Corporation |
Latex or pseudolatex compositions coatings and coating processes
|
US8299052B2
(en)
|
2006-05-05 |
2012-10-30 |
Shionogi Inc. |
Pharmaceutical compositions and methods for improved bacterial eradication
|
US10960077B2
(en)
|
2006-05-12 |
2021-03-30 |
Intellipharmaceutics Corp. |
Abuse and alcohol resistant drug composition
|
WO2007138606A2
(en)
*
|
2006-06-01 |
2007-12-06 |
Dexcel Pharma Technologies Ltd. |
Multiple unit pharmaceutical formulation
|
WO2008015530A2
(en)
*
|
2006-08-03 |
2008-02-07 |
Aurobindo Pharma Limited |
Stable solid oral formulation of pantoprazole
|
CN101484147B
(zh)
*
|
2006-08-18 |
2015-07-08 |
赢创罗姆有限责任公司 |
对于具有水中良好溶解性的活性成分具有受控的活性成分释放性的药物组合物
|
KR20170097787A
(ko)
|
2007-10-12 |
2017-08-28 |
다케다 파마슈티칼스 유에스에이, 인코포레이티드 |
음식 섭취와 관계없이 위장 장애를 치료하는 방법
|
CN101878041A
(zh)
*
|
2007-11-27 |
2010-11-03 |
大原药品工业株式会社 |
颗粒制剂的制造方法
|
US8911787B2
(en)
|
2008-02-26 |
2014-12-16 |
Ranbaxy Laboratories Limited |
Stable oral benzimidazole compositions and process of preparation thereof
|
EP2334178A4
(de)
*
|
2008-10-03 |
2012-04-11 |
Falk Pharma Gmbh |
Zusammensetzungen und verfahren zur behandlung von darmerkrankungen mit granuliertem mesalamin
|
EP2405898A2
(de)
|
2009-03-09 |
2012-01-18 |
Council Of Scientific & Industrial Research |
Zusammensetzung mit anhaltender freisetzung eines therapeutikums
|
US8663671B2
(en)
|
2009-11-05 |
2014-03-04 |
Philip Morris Usa Inc. |
Methods and compositions for producing hydrogel capsules coated for low permeability and physical integrity
|
WO2011080502A2
(en)
|
2009-12-29 |
2011-07-07 |
Orexo Ab |
New pharmaceutical dosage form for the treatment of gastric acid-related disorders
|
WO2011080500A2
(en)
|
2009-12-29 |
2011-07-07 |
Orexo Ab |
New pharmaceutical dosage form for the treatment of gastric acid-related disorders
|
US20150283083A1
(en)
*
|
2012-11-19 |
2015-10-08 |
Azanta A/S |
Dispersible Tablet
|
JP5934835B2
(ja)
*
|
2013-03-08 |
2016-06-15 |
富士フイルム株式会社 |
腸溶性細粒及び医薬組成物
|
US20140271845A1
(en)
*
|
2013-03-15 |
2014-09-18 |
Cerovene, Inc. |
Coated substrate compositions
|
WO2015115586A1
(ja)
*
|
2014-01-31 |
2015-08-06 |
塩野義製薬株式会社 |
徐放性製剤
|
EP3288556A4
(de)
|
2015-04-29 |
2018-09-19 |
Dexcel Pharma Technologies Ltd. |
Oral zerfallende zusammensetzungen
|
US10076494B2
(en)
|
2016-06-16 |
2018-09-18 |
Dexcel Pharma Technologies Ltd. |
Stable orally disintegrating pharmaceutical compositions
|
UY39094A
(es)
*
|
2020-02-27 |
2021-07-30 |
Hk Inno N Corp |
Composición farmacéutica que comprende compuesto derivado de bencimidazol
|